AGH Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
4,872
+121
+3% +$28.2K 0.78% 28
2026
Q1
$1.16M Buy
4,751
+237
+5% +$55.2K 0.85% 26
2025
Q4
$934K Sell
4,514
-373
-8% -$73.8K 0.7% 28
2025
Q3
$906K Buy
4,887
+326
+7% +$55.9K 0.66% 30
2025
Q2
$697K Sell
4,561
-92
-2% -$14.1K 0.57% 31
2025
Q1
$772K Buy
4,653
+153
+3% +$23.9K 0.74% 29
2024
Q4
$651K Buy
+4,500
New +$697K 0.6% 31

Other funds holding JNJ

AGH Wealth Advisors's JNJ Position: Q2 2026 in Review

AGH Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, buying an estimated $28.2K and bringing the position to 4,872 shares worth $1.24M. The position accounts for 0.78% of the portfolio, ranked #28.

AGH Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AGH Wealth Advisors held 4,872 shares of Johnson & Johnson worth $1.24M as of Q2 2026.
  • AGH Wealth Advisors bought 121 Johnson & Johnson shares in Q2 2026, an estimated $28.2K.
  • Johnson & Johnson made up 0.78% of AGH Wealth Advisors's portfolio in Q2 2026, its #28 holding.
  • AGH Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AGH Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.